<DOC>
	<DOC>NCT01210898</DOC>
	<brief_summary>This study will evaluate the safety and immunogenicity of children previously primed in the V70P5 study when revaccinated with adjuvanted or unadjuvanted seasonal influenza vaccine.</brief_summary>
	<brief_title>Immunogenicity and Safety of V70P5 Revaccination Subjects</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male or female children that have previously participated in the V70P5 study in Finland. Any condition which in the opinion of the investigator may interfere with the evaluation of the study objectives.</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>96 Months</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Trivalent</keyword>
	<keyword>Adjuvanted</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Children</keyword>
</DOC>